Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Pruritus to Dermatology Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Pruritus to Dermatology Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Pruritus Therapeutics Clinical Trials 28 Prominent Drugs 30 Clinical Trial Profile Snapshots 31 Appendix 142 Abbreviations 142 Definitions 142 Research Methodology 143 Secondary Research 143 About GlobalData 144 Contact Us 144 Disclaimer 144 Source 145

List of Tables Pruritus Therapeutics, Global, Clinical Trials by Region, 2016* 6 Pruritus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Pruritus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Pruritus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Pruritus Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Pruritus Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Pruritus Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13 Pruritus Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14 Proportion of Pruritus to Dermatology Clinical Trials, G7 Countries (%), 2016* 15 Pruritus Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Pruritus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Pruritus to Dermatology Clinical Trials, E7 Countries (%), 2016* 18 Pruritus Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Pruritus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Pruritus Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Pruritus Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Pruritus Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Pruritus Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Pruritus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Pruritus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Pruritus Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Pruritus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Pruritus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 List of Figures Pruritus Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Pruritus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Pruritus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Pruritus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Pruritus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Pruritus Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Pruritus Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 13 Pruritus Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14 Proportion of Pruritus to Dermatology Clinical Trials, G7 Countries (%), 2016* 15 Pruritus Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Pruritus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Pruritus to Dermatology Clinical Trials, E7 Countries (%), 2016* 18 Pruritus Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Pruritus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Pruritus Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Pruritus Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Pruritus Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Pruritus Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Pruritus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Pruritus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Pruritus Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Pruritus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Pruritus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 143

GlaxoSmithKline Plc Toray Industries, Inc. Trevi Therapeutics, Inc. Vanda Pharmaceuticals Inc. Amorepacific Corporation Allergan Plc Merck & Co., Inc. Dr. Reddy's Laboratories Limited Cara Therapeutics, Inc. C. H. Boehringer Sohn AG & Co. KG